Effect of filtered coffee intake in healthy subjects.

Not Applicable

• Conditions: risk reduction of cardiovascular disease; Inflammatory and Immune System - Other inflammatory or immune system disorders; risk reduction of Diabetes mellitus; atherogenesis prevention; Antioxidant activity of the coffee phenolic acids; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12609001064291
• Lead Sponsor: niversity of Sao Paulo (USP) - School of Public Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-12-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

All races, non-smokers or former-smokers for more than 2 years, non-alcoholics, serum cholesterol below 240 mg/dL, fasting glucose below 100 mg/dL, normal liver enzymes (Aspartate aminotransferase - AST and Alanine aminotransferase - ALT) and normal plasma homocysteine, absence of continuous medicine intake. No history of cardivascular, kidney or liver disease, diabetes mellitus, hypertension or hyperthyroidism.

Exclusion Criteria

Smoker or former-smoker for less than 2 years, alcoholic, serum cholesterol above 240 mg/dL, fasting glucose above 100mg/dL, altered liver enzymes, and normal plasma homocysteine; medication intake daily; presence or development of cardiovascular, kidney or liver disease, diabetes mellitus, hypertension or hyperthyroidism.

Study & Design

• Study Type: Interventional
• Study Design: Not specified